Development of live-attenuated arenavirus vaccines based on codon deoptimization - Wikidata - awgldk - TriplyDB

Development of live-attenuated arenavirus vaccines based on codon deoptimization

Development of live-attenuated arenavirus vaccines based on codon deoptimization

http://www.wikidata.org/entity/Q35487706

about

Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes Native functionality and therapeutic targeting of arenaviral glycoproteins Reverse Genetics Approaches for the Development of Influenza Vaccines An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection.Reverse Genetics Approaches to Control Arenavirus.Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure.Temperature-Sensitive Live-Attenuated Canine Influenza Virus H3N8 Vaccine Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines.General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines.The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.Lassa Virus Reverse Genetics.Evolutionary analysis of Old World arenaviruses reveals a major adaptive contribution of the viral polymerase.Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.Development of Recombinant Arenavirus-Based Vaccines.Codon optimization of the adenoviral fiber negatively impacts structural protein expression and viral fitness Development of a novel equine influenza virus live-attenuated vaccine.A vaccine platform against arenaviruses based on a recombinant hyper-attenuated Mopeia virus expressing heterologous glycoproteins.Zika Virus Attenuation by Codon Pair Deoptimization Induces Sterilizing Immunity in Mouse Models Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine

P2860

Q26742028-CD24EF9E-A1E0-4A4F-B7FE-7F2215C87843 Q26782411-9E5D1CE9-BE6C-4BEC-8C96-57DBA7BB80A2 Q26827679-EFD87C8B-4584-4E13-9BA9-A2E132D16F65 Q28076140-A310E634-9833-4DE7-A3EF-E24D7A28E2B3 Q33875495-7FDF83BF-0E76-42F0-A52F-D25210D16BBE Q37543755-0F28F383-920D-48C4-92F2-966B732D70CF Q37546745-E29F3089-5811-4807-9D6E-EA1BAF5D664A Q37599051-8DA618EC-9F3C-4097-A1D1-F358A518B8C5 Q38727207-0AC59227-DAAE-48D8-ACC5-B8EDA9E64C58 Q38818648-1D47FED5-4E16-4B0A-813C-833CFCADCA53 Q39097131-B62F9961-B7F4-4217-9A96-D15FAFAEFCF1 Q39602870-44781892-66AD-447B-A829-03323DC57FB1 Q40056797-E75A0EF4-4959-4236-91A5-2822025895EE Q40093891-F8858CC5-2F43-4AF4-9E79-2ECDB2C0F29B Q40150668-36056A7F-E646-4685-9C8D-F9F88CA013EC Q40156113-7234A924-B428-4E53-BE5C-167CA06E4219 Q40259618-C65A4841-BDF9-4C54-B589-054A6C2A2486 Q40640181-6F6807EB-BD20-45AC-A54A-1202BBB52AF5 Q50054245-0677950A-C594-439A-9759-FD0CE5437EAE Q52625005-C8E779EB-46D4-4284-B494-BF4F8039B95B Q56339878-4727D35A-F100-4AAB-9BEE-2F51C533F6F0 Q57466491-E6CC7347-A9BC-4DDD-840D-8E84FDC8BD3B

P2860

Development of live-attenuated arenavirus vaccines based on codon deoptimization

http://www.wikidata.org/entity/Q35487706

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

name

Development of live-attenuated arenavirus vaccines based on codon deoptimization

@ast

Development of live-attenuated arenavirus vaccines based on codon deoptimization

@en

type

label

Development of live-attenuated arenavirus vaccines based on codon deoptimization

@ast

Development of live-attenuated arenavirus vaccines based on codon deoptimization

@en

prefLabel

Development of live-attenuated arenavirus vaccines based on codon deoptimization

@ast

Development of live-attenuated arenavirus vaccines based on codon deoptimization

@en

P1433

Q35487706-95EE41E6-AEAC-4D2C-B39F-657A0491712B

P1476

Q35487706-4F619174-C422-4FB6-AE59-9CE235E9C40E

P2093

Q35487706-234789BF-36FF-4C76-A09A-6E9A6E8C76B9

Q35487706-A9F2ED2E-FEA6-45D3-93AC-D3FF3D4286B9

Q35487706-B5C1EB31-A016-4215-8A41-7E11927FA6F9

P2860

Q35487706-05E7FA0A-ACE4-4FEB-B53C-F867982F0442

Q35487706-06217EAB-FDF7-471F-BB77-B607A4007AFF

Q35487706-08B487CB-DC58-438C-A7AA-F807B03010C4

Q35487706-0E402F1A-A178-4F54-8B86-B312A8D06C72

Q35487706-12A50E59-230E-4B95-A2E5-7DB3DA4B4A35

Q35487706-134E2317-9989-4BB6-A480-CD0FA5BEC029

Q35487706-1F71FBA1-769F-45E9-B69B-459BE597413C

Q35487706-20B2660D-60A6-4B38-8F3F-CE88E0543D85

Q35487706-21797AD2-E770-45E4-B08F-325E6719C275

Q35487706-21C67422-4C8F-446E-89EC-7BB8941FB522

P304

Q35487706-EB872EEE-A038-4CB9-8ED4-7B2C74CCC0C0

P31

Q35487706-E38FE572-CFBE-44BD-B090-7CAC92EE6F29

P356

Q35487706-97630787-D2DC-446E-932E-2EB7D61D243F

P407

Q35487706-00761A96-E37E-4CDB-852D-2C9A51F1DAB4

P433

Q35487706-FCD4DC56-D533-44F8-BFC5-91C42DB67CAA

P478

Q35487706-FA09307D-358D-450A-9570-32876864BCBF

P50

Q35487706-5F44B8B0-7AE9-40FF-A13C-16716FADED3A

Q35487706-A68E8B41-5B7E-4BA7-AA49-1B7A9D886AE4

P577

Q35487706-45B7D230-79AF-4909-A902-9C8BB7F3AAB6

P698

Q35487706-F661FE99-30CE-4BE8-8B0E-A95AB92DB5A4

P921

Q35487706-DDE9E141-07E6-44D5-B6D3-D10D61BA7640

P932

Q35487706-396139FB-7EC9-44AF-B32D-3C76D3DF92E6

P356

P1433

Journal of Virology

P1476

Development of live-attenuated arenavirus vaccines based on codon deoptimization

@en

P2093

Benson Yee Hin Cheng

http://www.w3.org/2001/XMLSchema#string

Emilio Ortiz-Riaño

http://www.w3.org/2001/XMLSchema#string

Juan Carlos de la Torre

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa

Structural basis for the dsRNA specificity of the Lassa virus NP exonuclease

Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia

Development of a new vaccine for the prevention of Lassa fever.

NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

Mutation rates among RNA viruses

Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest

Advanced vaccine candidates for Lassa fever

Cap binding and immune evasion revealed by Lassa nucleoprotein structure

P304

3523-3533

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.03401-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

Luis Martinez-Sobrido

P577

2015-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25589652

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine

P932

4403387

http://www.w3.org/2001/XMLSchema#string